Related Experiment Video
Updated: Mar 20, 2026

Isolation of Lung Retinoid-Containing Cells by Cell Sorting
Published on: April 11, 2025
Should we still use vitamin A to prevent bronchopulmonary dysplasia?
X I Couroucli1, J L Placencia1, L A Cates1
1Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Insights
Vitamin A prophylaxis can prevent bronchopulmonary dysplasia (BPD) in preterm infants. This review evaluates evidence to guide decisions on its renewed, but costly, use.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Nutritional Science
Background:
- Bronchopulmonary dysplasia (BPD) causes significant morbidity in preterm infants.
- Vitamin A prophylaxis was historically used but became scarce.
- Renewed availability of Vitamin A at a higher cost presents a dilemma for routine use.
Purpose of the Study:
- To review evidence on Vitamin A for BPD prevention.
- To provide a framework for evaluating Vitamin A's value.
- To guide clinical and policy decisions regarding Vitamin A use.
Main Methods:
- Review of experimental data.
- Analysis of clinical trial evidence.
- Assessment of socioeconomic factors and cost-effectiveness.
Main Results:
- Vitamin A demonstrates efficacy in preventing BPD in certain preterm populations.
- Socioeconomic analysis is crucial due to increased cost.
- Evidence supports a targeted approach rather than universal prophylaxis.
Conclusions:
- Vitamin A remains a valuable tool for BPD prevention.
- Cost-benefit analysis is essential for current clinical practice.
- Decision-making should integrate clinical, economic, and policy considerations.
Abstract:
Bronchopulmonary dysplasia (BPD) is associated with significant short- and long-term morbidity in preterm infants, and it can be prevented in some infants with vitamin A prophylaxis. Vitamin A, once widely used in neonatal intensive care, was scarce for the last few years, but has become available again at a much higher price, leading to dilemmas about its routine use. In this review we discuss experimental, clinical and socioeconomic evidence related to BPD, and provide a framework for clinicians and policy-makers to evaluate the value of vitamin A treatment and make decisions about its use for prevention of BPD.
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Asthma-IV: Nursing Management
First, in...
Breathing
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
COPD: Management Using Bronchodilators and Corticosteroids
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

